Information Provided By: 
Fly News Breaks for March 18, 2015
AKRX
Mar 18, 2015 | 07:12 EDT
William Blair believes shares of Akorn "should recover strongly" with the uncertainty of the annual filing delay being lifted last night. The firm notes management reiterated that the restated financial estimates for 2014 do not affect 2015 guidance. Blair still expects Akorn's 2015 to be a year of "significant cash flow, opportunistic acquisitions, pipeline approvals, and strong growth despite clobetasol competition." It lowered its price target for shares to $58 from $60 and keeps an Outperform rating on the name.
News For AKRX From the Last 2 Days
There are no results for your query AKRX
